获批骨修复材料III 类医疗器械注册证,实现严肃医疗领域技术突破。公司自主研发的骨修复材料成功获得国家药监局 III 类医疗器械注册证,为骨缺损修复领域提供了全新解决方案。该材料专为牙颌骨与牙槽骨缺损修复设计,采用有机-无机复合材料,结合羟基磷灰石颗粒和大分子多糖的双重优势,模拟人体骨骼的无机成分,在生物相容性与力学性能上高度匹配。同时,多孔结构优化了成骨细胞的黏附、生长和分化环境,为新骨组织的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.